Employment Drug Testing for Employers

A pre-employment drug test is a screening conducted after a conditional job offer but before the employee starts work. It’s the most common type of workplace drug test and is typically required as a condition of employment. The candidate visits a collection site, provides a specimen (usually urine), and results are reviewed by a Medical Review Officer (MRO) before being reported to the employer.

A standard 5-panel drug test screens for marijuana (THC), cocaine, opiates (codeine, morphine, heroin), amphetamines (including methamphetamine), and phencyclidine (PCP). This is the federally mandated panel for DOT-regulated testing under 49 CFR Part 40 and is the most widely used panel for employment screening.

Negative results are typically available within 1–3 business days after the specimen reaches the lab. Non-negative (positive) results take longer because they require confirmation testing and review by a licensed Medical Review Officer (MRO), who contacts the donor to determine whether a legitimate medical explanation exists. This process usually adds 2–5 additional business days.

An MRO (Medical Review Officer) is a licensed physician trained in substance abuse testing who reviews all non-negative drug test results before they’re reported to the employer. The MRO contacts the donor to determine whether a legitimate medical explanation exists — for example, a valid prescription for a detected substance. MRO review is required for all DOT drug testing and is considered a best practice for non-DOT testing to protect both the employer and the donor from false positives.

DOT drug testing follows strict federal procedures outlined in 49 CFR Part 40 and is required for safety-sensitive employees regulated by agencies like FMCSA, FAA, FRA, FTA, PHMSA, and USCG. It mandates a specific 5-panel urine test, certified labs, MRO review, and specific collection procedures. Non-DOT testing is governed by state law and company policy, giving employers more flexibility in panel selection, specimen type, and testing occasions.

It depends on the state and the type of role. DOT-regulated employers must test for marijuana regardless of state law — federal regulations preempt state marijuana protections. For non-DOT employers, a growing number of states (including New York, California, and others) restrict or prohibit pre-employment marijuana testing for non-safety-sensitive positions. Employers should consult state-specific laws and legal counsel before including THC in their testing panel.

Detection windows vary by specimen type. Urine tests detect most substances within 1–30 days of use (marijuana can be longer for heavy users). Oral fluid (saliva) tests detect use within hours to 2–3 days. Hair follicle tests provide the longest window at approximately 90 days. The detection window also depends on the substance, frequency of use, metabolism, and the specific cutoff levels used by the lab.

Drug testing is often included as part of a comprehensive employment background check, but it is technically a separate process with different legal requirements. A background check searches criminal records, verifies employment and education, and checks references. Drug testing analyzes a biological specimen for the presence of controlled substances. Many employers order both simultaneously through a single provider like bchex to streamline the pre-employment process.

If a drug test returns a non-negative result, the MRO first contacts the donor to determine whether a legitimate medical explanation exists (such as a valid prescription). If no explanation is confirmed, the result is reported as positive to the employer. The employer then decides how to proceed based on company policy, applicable state law, and any collective bargaining agreements. For DOT-regulated employees, a positive result triggers mandatory removal from safety-sensitive duties and referral to a Substance Abuse Professional (SAP).

In most states, yes. Employers are generally required to provide advance notice that drug testing is a condition of employment, either in the job posting, the offer letter, or the company drug-free workplace policy. Some states require written notice and signed acknowledgment before testing can occur. DOT-regulated testing has its own notification requirements under 49 CFR Part 40.

A 10-panel drug test screens for the same five substances as a standard 5-panel (marijuana, cocaine, opiates, amphetamines, PCP) plus benzodiazepines, barbiturates, methadone, propoxyphene, and methaqualone (or expanded opioids, depending on the lab). It is commonly used for safety-sensitive non-DOT roles, government contractors, and employers who want broader coverage than the standard 5-panel provides.

Urine testing is the industry standard and is required for all DOT testing. It detects recent use within 1–30 days depending on the substance. Oral fluid (saliva) testing detects very recent use (within hours to 2–3 days) and is harder to adulterate because collection is observed. Hair follicle testing provides the longest detection window at approximately 90 days and is difficult to cheat, but it does not detect very recent use (within the past 5–7 days). Each method has trade-offs in detection window, cost, and adulteration risk.